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Abstract
Background: We set out to determine the magnitude of antigen-specific memory T helper cell responses to Pseudomonas
aeruginosa in healthy humans and patients with cystic fibrosis.
Methods: Peripheral blood human memory CD4+ T cells were co-cultured with dendritic cells that had been infected with
different strains of Pseudomonas aeruginosa. The T helper response was determined by measuring proliferation,
immunoassay of cytokine output, and immunostaining of intracellular cytokines.
Results: Healthy individuals and patients with cystic fibrosis had robust antigen-specific memory CD4+ T cell responses to
Pseudomonas aeruginosa that not only contained a Th1 and Th17 component but also Th22 cells. In contrast to previous
descriptions of human Th22 cells, these Pseudomonal-specific Th22 cells lacked the skin homing markers CCR4 or CCR10,
although were CCR6+. Healthy individuals and patients with cystic fibrosis had similar levels of Th22 cells, but the patient
group had significantly fewer Th17 cells in peripheral blood.
Conclusions: Th22 cells specific to Pseudomonas aeruginosa are induced in both healthy individuals and patients with cystic
fibrosis. Along with Th17 cells, they may play an important role in the pulmonary response to this microbe in patients with
cystic fibrosis and other conditions.
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Introduction
Cystic fibrosis (CF) typically results in recurrent pulmonary
infections and inflammation that produces progressive respiratory
failure [1,2]. The most common pathogen in these patients is
Pseudomonas aeruginosa (PA), which produces a neutrophil dominat-
ed host response that does not, however, clear the infection [3].
Indeed, this persistent inflammatory response contributes to
progressive lung injury [4,5] and thus pulmonary immune
responses to P. aeruginosa are a potential therapeutic target.
Colonization with this bacterium results in an antibody
response, which is not, however, protective [6]. In contrast, cell-
mediated immunity to P. aeruginosa is important in host defence [7].
Recently, attention has focused on the novel T helper 17 (Th17)
subset of Th cells [8]. These produce the signature cytokine IL-17
that plays a critical role in the generation and recruitment of
neutrophils to sites of infection. In experimental murine models of
acute pulmonary P. aeruginosa infection, there is evidence that
Th17 cells play a key role in vaccine-induced protection [9].
Human studies have shown IL-17 is produced in CF lung, and
that Th17 cells are present in the submucosa of airways from CF
patients, although IL-17 is also produced from innate immune
cells [10,11]. Humans typically have a very strong Th17 memory
response to Candida albicans as well as Staphylococcus aureus [12,13].
However, it is not known whether there are similar memory
responses to PA or whether these are altered in patients with CF.
IL-17 is commonly co-expressed with IL-22 in classic Th17
cells. IL-22 is a cytokine of the IL-10 family that has important
effects on non-immune cells, promoting repair of epithelial
surfaces and inducing an anti-microbial state [14]. More recently,
a distinct lineage of Th cells producing IL-22 in the absence of IL-
17 has been discovered, termed Th22 cells [15–18]. These cells
have been found to possess a skin homing phenotype and infiltrate
the skin in inflammatory disorders such as psoriasis in which IL-22
has been proposed to play a pathogenic role. In contrast, IL-22
also induces a variety of antimicrobial peptides and is important in
host defence against pulmonary pathogens such as Klebsiella
pneumonia [19]. Additionally, in a murine model of gut inflamma-
tion following infection with Citrobacter rodentium, IL-22 plays an
important role in host defence [20,21]. In this model, IL-22 is
produced both by innate lymphoid cells as well as Th22 cells [18].
IL-22 is also required to prevent dissemination of the commensal
enteric bacteria from the genus Alcaligenes [22]. As yet, no specific
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pathogen or antigen has been demonstrated to elicit a human
memory Th22 response.
Given that IL-22 promotes epithelial repair and induces an
antimicrobial state, we hypothesised that Th22 cells could play an
important role in host defence against lung infection with P.
aeruginosa in CF and other clinical settings. Additionally, given the
proposed role of Th17 cells in protection against PA infection, we
hypothesized that PA-specific Th17 cells would be found in
patients with CF. In order to test these hypotheses, we set out to
examine the Th22, Th17 and Th1 cell responses to P. aeruginosa in
both control and healthy individuals as well as patients with cystic
fibrosis. We found that both healthy individuals as well as those
with cystic fibrosis had robust antigen-specific Th17, Th1 and
Th22 responses to P. aeruginosa. The PA-specific Th22 cells were
CCR6+ but lacked the skin-homing receptors CCR4 and CCR10
that have previously been found on human Th22 cells. PA-specific
Th17 cells were reduced in patients with CF. These PA-specific
Th cell subsets represent novel effector cells that can modulate the
host anti-bacterial and inflammatory response to this pathogen
and hence could be targets for novel therapeutic interventions in
PA infection in CF and other conditions.
Materials and Methods
Ethics
All subjects gave informed written consent. The study was
approved by West of Scotland Research Ethics Committee
Number 2, a committee of the West of Scotland Research Ethics
Service (WoSRES) that oversees ethical review of studies carried
out on patients of the National Health Service Greater Glasgow
and Clyde Health Board.
Participants and Cell Isolation
Peripheral blood samples were collected from adult CF patients
attending the West of Scotland Adult CF Unit, Glasgow. Healthy
individuals (controls) had no history of respiratory disease or inter-
current illness. Participant characteristics are shown in Table 1.
Patients with CF attending the West of Scotland Adult CF Unit
are deemed to be chronically colonized with Pseudomonas aeruginosa
if sputum cultures remain positive for the organism after two
attempts to clear the organism with combination antibiotic
eradication therapy. Intermittent infection is deemed to exist
when PA has been isolated and eradicated via antibiotic therapy.
PBMCs were obtained by Ficoll-Paque gradient centrifugation
(GE Healthcare). CD14+ monocytes were then magnetically
isolated by a positive selection kit (Miltenyi Biotech). Memory
CD4+ T cells (purity for CD4+CD45RO+ .98%) were magneti-
cally isolated by a negative selection kit (Miltenyi Biotech). Memory
CD4+ T cells were further sorted into CCR6-enriched and CCR6-
depleted populations using positive selection microbeads (Stemcell
Technologies). Proliferation was measured with CFSE (carboxy-
fluorescein diacetate succinimidyl ester; Invitrogen) or proliferation
dye eFluorH450 (eBioscience) incorporated prior to cell culture.
Bacteriology
Laboratory P. aeruginosa (PA) strains PA103DpcrV and PA103-
DUDT [23,24] were kind gifts of Dr. Dara Frank, University of
Wisconsin. Both strains have modulation of the function of the
type three secretion system (T3SS), a common finding amongst CF
PA strains; PA103DpcrV lacks the pore-forming protein of the
T3SS rendering it non-functional and PA103DUDT lacks the
major translocation proteins (exoU and exoT) of the T3SS.
Clinical non-mucoid PA strains Yorkhill 1 and Yorkhill 2, and
clinical mucoid PA strain Yorkhill 5 were from CF samples
(provided by Dr Craig Williams, Royal Hospital for Sick Children,
Yorkhill). PA strains were grown to mid-log growth phase prior to
infection.
Cell Culture
Dendritic cells (DCs) were derived from CD14+ monocytes with
IL-4 (500 IU/mL; Peprotech) and GM-CSF (50 ng/mL; Pepro-
tech) for 7-days. DCs were infected with live PA strains as
indicated. Ninety-minutes following infection, DCs were treated
with bactericidal antibiotics (100 U/mL penicillin-streptomycin
and 10 mg/mL gentamicin; both Sigma) followed by overnight
incubation. Additionally, in some experiments, DCs were treated
with tetanus toxoid (5 ug/mL; Calbiochem) or heat-killed
preparation of Candida albicans (InvivoGen).
Infected DCs (16104 cells) were cultured with autologous
memory CD4+ T cells (16105 cells) in 96-well U-bottom plates in
IMDM+Glutamax medium (Gibco Life Technologies) supple-
mented with 5% fetal bovine serum (Invitrogen) and 100 U/mL
penicillin-streptomycin for 6-days. For polyclonal stimulation
conditions, CD4+ T cells were cultured with plate-bound anti-
CD3 (5 ug/mL) and soluble anti-CD28 (1 ug/mL) (both
eBioscience).
Measurement of CD4+ T cell response
Following 6-days of co-culture, supernatants were harvested and
cytokine levels measured via ELISA for IL-17A, IL-22, and IFN-c
(eBioscience).
Cell Staining and Analysis
Cells were stimulated for 5-hours with phorbol 12-myristate 13-
acetate (50 ng/ml; Sigma) and ionomycin (500 ng/ml; Sigma) in
Table 1. Characteristics of participants providing peripheral blood specimens for the analysis of T helper cell responses to
Pseudomonas aeruginosa.
Patients with cystic fibrosis Healthy controls
Participants (n) 8 10
Age, median (IQR), years 23 (23.5–30) 26 (24–29)
Male sex, n (%) 5 (62.5) 4 (40)
Chronic Pseudomonas aeruginosa colonization, n 7 na
FEV1 median (IQR), % predicted 38.2 (35.2–44.4) na
No. of patients with respiratory exacerbation at time of sample collection, n (%) 6 (75) na
n, number in group; na, non-applicable; IQR, inter-quartile range; FEV1, forced expiratory volume in 1 second.
doi:10.1371/journal.pone.0090263.t001
Th Cells in Cystic Fibrosis
PLOS ONE | www.plosone.org 2 February 2014 | Volume 9 | Issue 2 | e90263
the presence of Golgiplug (1 ml/ml; BD Pharmingen) at 37uC.
Cells were fixed using 4% paraformaldehyde (VWR International)
and made permeable, following extracellular staining, using
Perm/Wash (BD Biosciences).
Extracellular staining was with phycoerythrin-labelled anti-CD4
(RPA-T4; eBioscience), phycoerythrin-labelled anti-abTCR (IP26;
eBioscience), phycoerythrin-Cy7-labelled anti-CCR4 (IGI; BD
Pharminogen), AlexFluorH647-labelled anti-CCR9 (BL/CCR9;
BioLegend), phycoerythrin-labelled anti-CCR10 (FAB 3478P;
R&D), CD86 and CD40. Intracellular staining was with
eFluorH660-labelled anti-IL-22 (22URTI; eBioscience), phycoery-
thrin-labelled anti-IL-22 (BG/IL-22; Biolegend), PerCP-Cy5.5-
labelled anti-IFN-c (4S.B3; eBioscience), and AlexFluorH488 anti-
IL-17A (eBioDEC17; eBioscience). Corresponding isotype controls
were used. Dead cell exclusion was achieved either by Boolean-
gating based on cell scatter properties or labelling with Fixable
Viability Dye eFluorH506 (eBioscience). Stained cells were
analysed on either a FACSCalibur or CyAn flow cytometer (BD
Biosciences). Collected data were analysed using FlowJo software
(Tree Star).
Statistical analysis
Non-parametric statistical tests were used (Mann-Whitney,
Kruskal-Wallis (KW), and, where appropriate, Dunn’s multiple
comparison test), using Prism Version 6.0 (GraphPad Software).
Results
Antigen-specific memory CD4+ T cell responses exist
against P. aeruginosa in Healthy Individuals
In order to examine antigen-dependent T cell memory
responses from healthy controls and patients with CF, we isolated
monocyte-derived dendritic cells (DCs) and CD4+CD45RA2C-
D45RO+ memory T cells from peripheral blood. Memory CD4+
T cells were co-cultured with either uninfected DCs, DCs infected
with PA, or the supernatant of such DCs, and the production of
IL-17A, IL-22 and IFN-c measured in the culture supernatant by
ELISA (Figure 1).
Firstly, we examined the memory T cell responses of healthy
controls. Small amounts of IL-17A were produced by T cells
cultured with unstimulated DCs; this was abolished in the absence
of DCs (Figure 1A). In the absence of DC infection, there was no
significant production of either IL-22 (Figure 1B) or IFN-c
(Figure 1C). In contrast, co-culture of memory T cells with DCs
infected with PA103 gave robust production of IL-17A, IL-22 and
IFN-c (Figure 1). This was almost completely abolished when T
cells were cultured with infected DC supernatants alone (Figure 1);
thus direct contact between T cells and DCs is required for
cytokine production. No cytokines were produced when T cells
were infected directly in the absence of DCs or when infected DCs
were cultured alone in the absence of T cells (data not shown).
Thus, the observed memory Th cell responses in healthy
individuals were entirely dependent on physical contact between
the DCs and T cells, as expected of an antigen-driven response.
Cytokine production did not vary significantly following co-culture
of memory T cells with DCs infected at multiplicities of infection
(MOIs) between 10–60 (Figure 1D–F), suggesting even at the
lowest MOI used the stimulating effect on memory T cells was
already maximal.
Next, we compared this cytokine production by memory CD4+
T cells in healthy individuals against different strains of PA.
Similar levels of these three cytokines were produced following
infection of DCs with strains of PA103 that differed in the
possession of a functional type III apparatus (Figure S1).
Additionally, these cytokine levels did not vary significantly
between these laboratory strains and the response to PA strains
isolated from patients with CF (Figure S1).
We then examined the proliferation of memory CD4+ T cells of
healthy individuals following co-culture with DCs alone or DCs
infected with PA, using a flow cytometric method. As expected,
little proliferation was seen with T cells cultured with uninfected
DCs (Figure 2A). However, marked proliferation of CD4+ T cell
was seen in response to DCs infected with either laboratory
PA103DUDT (average proliferation [+/2SEM] 18.8% [+/
29.0%] for three donors) and clinical Yorkhill 5 (average
proliferation [+/2SEM] 35.1% [+/25.2%] for three donors)
PA strains (Figure 2A). We also stained these cells for the presence
of intracellular cytokines to determine which cells were producing
the measured cytokines. IL-17 and IL-22 production in the co-
cultures was predominantly by cells proliferating in response to PA
(Figure 2B and C). Proliferating cells producing intracellular IL-17
and/or IL-22 were also confirmed to be ab T cell receptor positive
cells (data not shown). No intracellular cytokines were produced in
DCs. Small amounts of intracellular IFN-c were expressed by the
non-proliferating CD4+ memory cells following polyclonal stimu-
lation; however, IFN-c was only secreted from memory CD4+ T
cells in response to PA infected DCs (Figure 1). Collectively, these
data show the existence of a classical antigen-specific memory
CD4+ T cell response to P. aeruginosa in healthy individuals with no
previous history of pulmonary infection with this organism.
DC Activation following Infection with P. aeruginosa
To explore potential differential effects of the different PA
strains on DC activation, we stained DCs for the activation
markers CD86 and CD40 following infection with the different PA
strains (Figure 3). Figure 3A shows representative plots of flow
cytometric analysis of CD86 and CD 40 on the surface of DCs
following infection with PA103DUDT and Yorkhill 1 strains of PA
as well as exposure to heat killed Candida albicans. These examples
all show a marked upregulation of these activation markers on the
surface of DCs. This was quantified for both CD86 and CD40 for
a range of strains as shown in Figure 3B and 3C respectively. All
strains tested produced an increase in expression of these markers.
There was a trend towards slightly higher levels of expression in
DCs infected with the PA103 strains, but this did not reach
statistical significance.
Cytokine secretion by P. aeruginosa-specific CD4+ T cells
in patients with CF and controls
We then examined the cytokine responses of peripheral memory
T cells in response to PA infected DCs in patients with CF
compared to healthy individuals. All CF patients had a history of
chronic or intermittent PA infection (Table 1). As seen in the
experiments with T cells from healthy control individuals, memory
CD4+ T cells from patients with CF produce significant amounts
of IL-17A, IL-22 and IFN-c in response to DC infection with
either laboratory or clinical PA strains compared with uninfected
DCs (Figure 4A, B and C). However, the magnitude of this
response between patients with CF with a history of P. aeruginosa
infection and healthy controls was not significantly different for all
three of the cytokines measured (p.0.05 for all strains, Kruskal
Wallis).
P. aeruginosa-specific Th22, Th17 and Th1 responses in
patients with CF and controls
Further to assess the Th cell subsets constituting the memory
CD4+ T cell response to PA, we used polyclonal re-stimulation
Th Cells in Cystic Fibrosis
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and intracellular staining of the resultant CD4+ T cell populations
present at the end of the co-cultures followed by flow cytometric
analysis. Th1 cells are characterized by their production of IFN-c
on antigen stimulation. In humans, Th1 cells can co-produce IL-
17 and IL-22, which was indeed initially classed as a Th1 cytokine
[25]. To provide an unambiguous classification of the different
cytokine producing cells, we adopted the following definitions.
CD4+ T cells expressing IFN-c were designated as Th1 cells; Th17
cells were any IFN-c negative cell producing IL-17A with/without
IL-22; and Th22 cells were defined as those expressing IL-22 alone
(Figure 5A). We used this gating strategy to quantify the
proportions of memory CD4+ T cells in each of these categories
following stimulation with PA-infected DCs.
Figure 1. Cytokine production of human memory CD4+ T cells in response to P. aeruginosa. A–C Sorted human memory CD4+ T cells from
healthy volunteers were co-cultured either with dendritic cells that had been infected with P. aeruginosa (DCs +) or with the supernatant from such
infected DCs (DC2). Levels of IL-17A (A), IL-22 (B) and IFN-c (C) were measured in supernatants after 6 days. DCs were infected at a MOI of 60 before
culturing with T cells. Columns show the mean of triplicate determinations; error bars are 61 standard error of mean. Results are representative of
experiments in three separate individuals. D–F, secreted cytokine levels following DC infection at a variety of different MOIs. Each point represents a
value from an individual healthy individual.
doi:10.1371/journal.pone.0090263.g001
Th Cells in Cystic Fibrosis
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In healthy controls (Figure 5B) and patients with CF (Figure 5C)
the predominant responding population was a memory Th1
response. Within the population of IFN-c positive cells prolifer-
ating in response to PA infected DCs, there were cells that that co-
produced IL-17 and/or IL-22 (Figure 2C). Significantly, however,
there were clear populations of Th22 and Th17 cells, as defined
above, i.e. IFN-c2 IL-172 IL-22+ and IFN-c2 IL-17+ respectively
(Figure 5). The proportion of Th1 and Th22 cells detected
following co-culture with PA infected DCs was similar in healthy
controls and patients with CF (see Figure S2). However, although
the observed IL-17A cytokine response was of a similar magnitude
(Figure 4A), there was a significantly lower proportion of Th17
cells in CF patients compared with healthy controls (Figure 5D).
This was particularly evident in response to the clinical PA strains,
where median percentage of Th17 cells was 5.3% in healthy
controls compared with 1.04% in CF patients (p = 0.003).
These cytokine profiles were in distinct contrast to those
obtained from memory CD4+ T helper cells that were stimulated
with either tetanus-toxoid treated DCs (Figure S3A, B) or heat-
killed Candida albicans (Figure S3C, D). Tetanus-toxoid induced, as
predicted, an essentially pure Th1 response. Candida albicans, as has
been previously described [26], induced a robust Th17 response,
although Th1 and Th22 cells were also evident.
Tissue-homing characteristics of-specific memory Th22
and Th17 cells
Human memory Th17 and Th22 cells characteristically express
the mucosal chemokine receptor CCR6 [13,16,17]. To further
verify the existence of memory Th17 and Th22 populations
against PA, we sorted memory CD4+ T cells on the basis of their
CCR6 expression prior to culture with PA-infected DCs. This
confirmed that virtually all IFN-c negative CD4+ T cell producing
IL-17A and/or IL-22 (i.e. Th17 and Th22 cells) in response to PA
infection were in the CCR6-enriched population (Figure 6A, B
and C).
Figure 2. Cell proliferation of memory CD4+ T cells following co-culture with infected dendritic cells (DCs). (A) Memory CD4+ T cells
loaded with proliferation dye were co-cultured with unstimulated DCs, DCs infected with PA103DUDT MOI 30 (PA103), or DCs infected with Yorkhill 5
MOI 30 (Yorkhill 5). Panels show the distribution of the proliferation dye fluorescence in the cell population after 6-days; inset figures show the
percentage of the initial population that has undergone one or more cell divisions. (B) Patterns of cytokine expression by non-proliferating CD4+ T
cells following 6-days of culture with DCs infected with Yorkhill 5. (C) Patterns of cytokine expression by CD4+ T cells proliferating in response to
culture with DCs infected with Yorkhill 5. Numbers in plot represent per cent cells in each quadrant. The experiment was repeated in 3 independent
individuals with the same result.
doi:10.1371/journal.pone.0090263.g002
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We next addressed whether the PA-specific memory Th17 and
Th22 populations demonstrated features of homing to specific
tissues. Th22 cells have previously been found to demonstrate a
skin-homing phenotype [13,16,17] and have been implicated in
the pathogenesis of inflammatory skin conditions [15]. We thus
analysed the PA-specific memory IL-22 secreting cell population
for expression of the skin-homing receptors CCR4 and CCR10. In
contrast to the reported properties of peripheral blood derived
Th22 cells without a characterised antigen specificity [16,17], IL-
22 production in response to PA infection was from memory
CD4+ T cells that did not express the skin-homing receptors
CCR4 or CCR10 (Figure 6D). Additionally, we found that PA-
specific IL-17A and IL-22 expressing memory T helper cells did
not display the gut-homing receptor CCR9 (Figure 6D).
Discussion
The work described in this paper provides an important
advance in our understanding of the human T helper response to
P. aeruginosa and how this might influence the course of lung
disease in individuals with CF who are chronically colonized with
this microbe, as well as in other patients with PA infections. We
found robust memory Th responses to P. aeruginosa in both normal
individuals and in those with CF who have Pseudomonas
colonization of the respiratory tract. These specific responses to
P. aeruginosa contain Th1, Th17 and Th22 cells. This is the first
time that an antigen-specific human Th22 response has been
demonstrated. Moreover, these cells have a novel phenotype,
lacking homing markers for skin and gut although retaining
CCR6, which would allow them to respond to the ligands CCL20
Figure 3. DC Activation following infection with different strains of P. aeruginosa. Levels of CD86 (A) and CD40 (B) following DC activation
24 hours following treatment with the indicated microbes. The panels show representative plots of isotype staining (solid shading), staining of
unstimulated DCs (solid line) and staining following microbial treatment (dotted line). B and C, mean fold-increase in mean fluorescence intensity
(MFI) of CD86 and CD40 respectively in 5 independent individuals. This was calculated as the fold-increase in MFI in infected DCs versus uninfected
controls. Columns show mean and SEM.
doi:10.1371/journal.pone.0090263.g003
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and b-defensins produced from damaged epithelia. We show that
although Th22 and Th1 responses are similar in controls and
patients with CF, the proportion of Th17 responding cells is
significantly diminished in peripheral blood of patients with CF.
Taken together, these data show that chronic airway colonization
with P. aeruginosa could activate both Th17 and Th22 memory
responses that would migrate to inflamed lung, and potentially
alter the balance between inflammation, host defence and tissue
repair.
The most striking finding of this study was the identification of
Pseudomonal-specific Th22 cells in both healthy individuals and in
those with CF. We were surprised that normal healthy controls
had robust Th22 (and indeed Th1 and Th17) responses to P.
aeruginosa, as it is generally only pathogenic in immunocompro-
mised states. The microbe is found within the bowel flora of a
minority of normal individuals, 4% in one report [27], so it would
not seem likely that this is the source of bacteria to provoke a
memory Th response. Indeed, the Pseudomonal-specific Th22
cells we identified did not have gut or skin homing receptors (Fig 6).
Although P. aeruginosa is a common environmental organism, it
remains unclear at what site this microbe triggers a memory T
helper response. Others have also demonstrated cross-reactivity of
Th17 cells against different bacterial serotypes and fungi [28,29].
We have not sought to define the antigenic component, of which
there may be many, of Pseudomonas aeruginosa eliciting the observed
Th17 and Th22 response, which might be shared with other
infecting organisms and particularly with other Gram negative
bacteria. The possibility of cross-reactivity of these Th cell
responses remains, yet we have shown a lack of gut-homing and
thus cross-reactivity with phylogenetically-related organisms in gut
flora is unlikely.
In common with previous descriptions of Th22 cells in humans,
the Pseudomonal-specific Th22 cells we identified were in the
CCR6+ population (Figure 6) [15–17]. Previous studies identified
these cells as bearing skin-homing markers and a pathogenic role
for these cells in psoriasis and other inflammatory skin disorders
Figure 4. Cytokine production by humanmemory CD4+ T cells in healthy controls and cystic fibrosis. Human memory CD4+ T cells were
exposed to unstimulated DCs or DCs infected with the laboratory strains (PA103) or clinical Pseudomonas aeruginosa strains (Yorkhill). After 6 days of
co-culture levels of (A) IL-17, (B) IL-22 and (C) IFN-c were measured. Each point represents the mean of triplicate wells and is the result from one
individual. The different bacterial strains used are:¤, unstimulated;#, PA103 DpcrV;N, PA103DUDT;m, YH1;&, YH2;6, YH5. The line indicates the
median value. Differences between infection conditions (A–C) were evaluated by a Kruskal-Wallis test all of which had p values,0.0009). Differences
between unstimulated and infected conditions were then tested using Dunn’s multiple comparison test. ** significant p,0.01 and *** significant
p,0.001.
doi:10.1371/journal.pone.0090263.g004
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has been proposed. We propose that the pseudomonal-specific
Th22 cells we have identified in healthy humans and patients with
CF can migrate to inflamed lung, which will release the
chemokines CCL20 and b-defensins, both ligands for CCR6. In
relation to pulmonary recruitment, we have previously sought
evidence of Th17 and Th22 recruitment within bronchoalveolar
lavage (BAL) from CF patients, an approach that has significant
technical limitations. We have, however, identified low level IL-22
production (IL-22 detectable in 5 of 14 CF patients, with median
IL-22 levels of 12.39pg/mL) within the CF BAL and thus further
implicating a potential Th22 response within the disease
pathogenesis. Given its potent action in promoting epithelial
repair, regulating fibrosis and mediating host defense [14,19,30],
we believe that IL-22 is important in attenuating the effects of
chronic pulmonary infection with P. aeruginosa and enhancing
tissue repair. The action of IL-22 may well be modified by IL-17,
as demonstrated in lung fibrosis [30]. Testing of this hypothesis
will best be performed in an animal model of chronic P. aeruginosa
lung infection. We found in general that IL-22 production in the T
cell memory population was predominantly from Th22 cells more
than Th17 cells (Figures 2 and 6). As outlined above, these cells
would be able to migrate to inflamed tissue producing the CCR6
ligands CCL20 and b-defensins, both of which would be found in
infected lung. The swift expansion of a PA-specific Th22 memory
cell population would thus ensure a rapid production of an IL-22
producing cell that could migrate to the site of infection to mediate
host defence and/or contribute to tissue repair.
A very recent study from Jay Kolls’ group identified Pseudo-
monal-specific Th17 cells in the draining lymph nodes of patients
with CF [31]. Intriguingly, we found a reduction in Pseudomonal-
specific Th17 cells in peripheral blood of CF patients. These data
suggest that this Th17 population translocates from blood to
pulmonary system during the chronic pulmonary colonization
with P. aeruginosa. Indeed, IL-17+ T cells and IL-17 production has
previously been observed within CF lung [10] and BAL [32],
respectively. Alternatively, a recent study demonstrated that PA
can induce myeloid-derived suppressor cells via flagellin stimula-
tion [33]. These cells could act to down-regulate Th17 responses
to PA, accounting for the observed reduction in PA-specific Th17
cells in CF patients.
Within the CF patient population exogenous and endogenous
factors which may modulate immune function are common. For
example, within our sampled CF population all patients were
receiving long-term low-dose macrolide therapy and a quarter had
CF-related diabetes mellitus. Nutritional status of CF patients will
also be worse than age-matched controls. Controlling for such
variables is problematic without a large sample size, which would be
prohibitive for our described method of ex vivoT cell stimulation.We
did however achieve adequate age matching of CF patients and
controls, as well as ensuring that controls were healthy and free from
conditions linked to pulmonary Th17 responses and pulmonary
Pseudomonas infections, such as asthma and bronchiectasis. The
data identifies and describes a previously uncharacterized Th cell
response against Pseudomonas aeruginosa in both healthy controls and
patients with CF, however generalizations to the whole heteroge-
neous CF population are preliminary at present.
Although this study has focussed on PA-specific Th cells in
patients with cystic fibrosis, PA infections are significant in
immunocompromised patients [34], in ventilator-associated pneu-
monia [35], following extensive burns and as a cause of infective
exacerbations in patients with chronic obstructive airways disease
[36]. Thus, the presence of Th22, Th17 and Th1 memory CD4+
cells specific to PA may play a role in these situations as well. The
balance of effects on host defence, tissue repair and systemic
inflammation produced by Il-22 will likely differ between these
different conditions, necessitating further experimental investiga-
tion to define the role of IL-22 and Th22 cells in each of these
conditions.
In conclusion, our work has demonstrated the presence in
peripheral blood of memory CD4+ T cells of the Th22 lineage that
are specific for P. aeruginosa antigens. They lack conventional skin
Figure 5. Memory CD4+ T cells subset response to different
Pseudomonas strains in CF and controls. Following co-culture
with dendritic cells infected with laboratory Pseudomonas aeruginosa
(PA) strains (PA103) or clinical PA strains (Yorkhill), CD4+ T cells were
classified into T helper cell subsets based on intracellular cytokine
straining patterns, as shown for a representative patient in panel A. The
Th1, Th17 and Th22 responses to both PA103 and Yorkhill PA strains is
shown for healthy controls (B) and patients with CF (C), as a percentage
of the total numbers of CD4+ memory cells analysed. The columns show
the mean values +/2 SEM; n= 8 for CF patients and 10 for healthy
controls. Panel D shows the proportions of PA-specific Th17 cells in CF
patients compared with controls. Each point represents the result from
one individual; different bacterial strains are indicated by the symbols
as described in Figure 4. The line indicates the median value.
Differences between controls and patients with CF (D) were evaluated
by a Mann-Whitney test.
doi:10.1371/journal.pone.0090263.g005
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or gut homing markers but are CCR6+. We propose that these
cells will migrate to areas of inflamed lung under the influence of
CCL20 or b-defensins. Local IL-22 within the lung could play a
key role in host defence, epithelial repair and regeneration, and
may be amenable to therapeutic intervention to promote healthy
lung repair after damaging infection.
Supporting Information
Figure S1 Cytokine production by human memory
CD4+ T cells to different Pseudomonas aeruginosa
strains. Human memory CD4+ T cells from healthy volunteers
(A, B and C) and patients with cystic fibrosis (CF) (D, E and F)
were co-cultured with dendritic cells infected with different strains
of (PA). Laboratory PA strains PA103 DpcrV and PA103 DUDT,
clinical non-mucoid strains Yorkhill 1 and 2, and the clinical
mucoid strain Yorkhill 5 were used; clinical strains were derived
from cystic fibrosis patients. Levels of cytokines were measured in
the supernatant after 6-days of culture. Each point represents the
result from one individual; an individual may be represented more
than once by separate experiments. The line indicates the
median value. Differences between strains were evaluated by a
Kruskal-Wallis (KW) test with pairwise assessments of differences
between groups made using Dunn’s multiple comparison test. *,
significance difference ,0.05. Only minor differences were seen in
the cytokine response to different strains of PA in both healthy
controls and patients with CF.
(TIF)
Figure S2 Memory CD4+ T cells subset response to
different Pseudomonas strains in CF and controls. The
proportion of PA specific CD4+ T helper cell responses to PA103
(PA103 DpcrV and PA103 DUDT) and Yorkhill strains (Yorkhill
1, 2 and 5) that are Th1 (A) or Th22 (B) was determined as
outlined in Figure 5 in the main text. Each point represents the
result from one individual; some individuals were tested against
different bacterial strains as indicated by the symbols used in
Figure 4. The line indicates the median value. Differences between
controls and patients with CF were evaluated by a Mann-Whitney
test with the p value as shown.
(TIF)
Figure S3 Cytokine production by humanmemory CD4+
T cells to tetanus toxoid and heat-killed candida albicans.
Human memory CD4+ T cells from healthy were co-cultured with
dendritic cells infected with tetanus toxoid or heat-killed candida
Figure 6. Tissue-homing characteristics of Pseudomonas aeruginosa-specific memory Th22 and Th17 cells. A–C Human memory CD4+
T cells were sorted into CCR6-depleted (CCR6 negative) and CCR6-enriched (CCR6 positive) populations before being exposed to dendritic cells (DCs)
infected with Yorkhill 5 MOI30 (A), DCs infected with PA103 DUDT MOI30 (B), or stimulated with anti-CD3 and anti-CD28 which acted as a positive
control by polyclonal T cell stimulation (C). Plots show CD4+ IFN-c negative T cells after 6-days of co-culture. D Memory CD4+ T cells were cultured
with DCs infected with PA103 DpcrV MOI30. Pseudomonas-specific memory CD4+ T cells were analysed for expression of intracellular IL-22 or IL-17 as
shown together with the skin-homing chemokine receptors CCR4, CCR10 and CCR9 as indicated. Numbers in each plot represent per cent cells in
each quadrant. Results are representative of those seen in three independent individuals.
doi:10.1371/journal.pone.0090263.g006
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albicans. (A) Patterns of cytokine expression by non-proliferating
CD4+ T cells following 6-days of culture with DCs infected with
tetanus toxoid. (B) Patterns of cytokine expression by CD4+ T cells
proliferating in response to culture with DCs infected with tetanus
toxoid. (C) Patterns of cytokine expression by non-proliferating
CD4+ T cells following 6-days of culture with DCs infected with
heat-killed candida albicans (HKCA). (D) Patterns of cytokine
expression by CD4+ T cells proliferating in response to culture with
DCs infected with HKCA. Numbers in plot represent percent cells
in each quadrant.
(TIF)
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